Disruption in distribution

Summary: A fragmented, old-school drug-supply chain is getting rebuilt by a tech-first disruptor. Here’s how Entero Healthcare is scaling faster than rivals, lifting margins and navigating the risks that come with a high-velocity consolidation play. If there’s one corner of India’s vast healthcare ecosystem that has quietly resisted formalisation, it is pharmaceutical distribution. It usually takes thousands of small family-run wholesalers, manual inventory books and a web of middlemen for your medicines to reach your local chemist. But one small business, Entero Healthcare Solutions, is rewriting that story with India’s first integrated, tech-enabled platform for healthcare product distribution. Founded in 2018 by industry veterans Prabhat Agrawal and Prem Sethi, Entero Healthcare stands out in a market dominated by unorganised distributors with its platform model, which connects over 2,600 healthcare product manufacturers with more than 71,000 pharmacies and 2,500 hospitals through a single digital interface. In the seven years since its inception, the company has achieved a healthy scale with revenue of Rs 5,096 crore in FY25 and a network that now spans 469 districts, 102 warehouses and over 74,000 unique products. The platform advantage Entero’s proprietary technology stack includes Entero Direct, its digital ordering platform; Teqtic, an analytics engine that provides inventory and demand visibility; and an integrated system of customer relationship manag